WallStSmart

ENvue Medical Inc. (FEED)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 1158543% more annual revenue ($25.27B vs $2.18M). SYK leads profitability with a 13.2% profit margin vs 0.0%. SYK earns a higher WallStSmart Score of 55/100 (C-).

FEED

Avoid

30

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 2/9Altman Z: -1.85

SYK

Buy

55

out of 100

Grade: C-

Growth: 6.0Profit: 6.5Value: 3.3Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for FEED.

SYKSignificantly Overvalued (-49.0%)

Margin of Safety

-49.0%

Fair Value

$223.22

Current Price

$326.54

$103.32 premium

UndervaluedFair: $223.22Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FEED2 strengths · Avg: 10.0/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$127.55B9/10

Large-cap with strong market position

Areas to Watch

FEED4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$3.14M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

SYK4 concerns · Avg: 3.8/10
PEG RatioValuation
1.584/10

Expensive relative to growth rate

P/E RatioValuation
38.5x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : FEED

The strongest argument for FEED centers on Price/Book, Debt/Equity.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap.

Bear Case : FEED

The primary concerns for FEED are EPS Growth, Market Cap, Profit Margin.

Bear Case : SYK

The primary concerns for SYK are PEG Ratio, P/E Ratio, Revenue Growth.

Key Dynamics to Monitor

FEED carries more volatility with a beta of 1.50 — expect wider price swings.

SYK is growing revenue faster at 2.6% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SYK scores higher overall (55/100 vs 30/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ENvue Medical Inc.

HEALTHCARE · MEDICAL DEVICES · USA

ENvue Medical Inc. (FEED) is an innovative healthcare technology company dedicated to enhancing patient care management through cutting-edge medical devices and integrated software solutions. By leveraging advanced technology, ENvue aims to streamline recovery processes and optimize health outcomes across diverse clinical environments. With a strong pipeline of products and strategic partnerships, the company is well-equipped to capitalize on the expanding opportunities in the healthcare sector, making it an attractive investment prospect for institutional investors interested in the evolution of medical devices and digital health innovations.

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?